PRB1 and systemic sclerosis: Indeed, up to 95% of SSc patients [1] have circulating autoantibodies directed against one or more autoantigens, including topoisomerase I (formerly called Scl-70), centromere proteins (CENPs), RNA polymerase III, and the PM/Scl complex, also known as the human exosome [2].